["{\n\"step_by_step_thinking\": \"From the provided documents, it is clear that quality of life assessment has been included as a variable in clinical trials for lung cancer patients. In one study, an independent prognostic variable for survival was identified, which was patient-rated quality of life. This suggests that self-reported health-related quality of life can be a prognostic factor for survival in non-small-cell lung cancer patients. Furthermore, the documents suggest that quality of life assessment is important for predicting treatment outcome and should be evaluated as a potential predictor of survival in clinical trials.\",\n\"answer_choice\": A"]